摘要
目的：观察阿司咪唑治疗哮喘的疗效。方法：４４例轻、中度支气管哮喘病人（男性２４例，女性２０例，年龄２７ａ±ｓ７ａ）口服阿司咪唑２０ｍｇ，ｑｄ，疗程４ｗｋ。结果：服药后症状评分显著减少。ＰＥＦＲ，ＦＥＶ１和ＦＥＶ１％显著提高（Ｐ＜０．０１），未见明显不良反应。结论：阿司咪唑是一种治疗轻、中度哮喘的安全有效的药物。
AIM: To observe the efficacy of astemizole in treating bronchial asthma. METHODS: Forty_four patients (M 24, F 20; age 27 a±s 7 a) with bronchial asthma of mild or moderate degree were treated with astemizole (20 mg, po, qd) for 4 wk. RESULTS: Symptom scores were decreased after using astemizole. PEFR, FEV 1, and FEV 1% increased at the end of this trial (P<0.01). No serious adverse reaction was observed. CONCLUSION: Astemizole is a safe and effective drug for mild to moderate bronchial asthma.
出处
《中国新药与临床杂志》
CAS
CSCD
北大核心
1999年第1期36-37,共2页
Chinese Journal of New Drugs and Clinical Remedies
